Cargando…
The cost of cancer care is not related to its outcomes
Solid tumours make up 90% of all proliferative diseases and the main action for cure remains surgery, removing the visible tumour as well as the surrounding tissue. Radiotherapy is an added value for eliminating local microscopic as well as regional disease. Systemic treatment has a small impact on...
Autores principales: | Storme, Guy, Dhaese, S, Corens, D, De Ridder, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130330/ https://www.ncbi.nlm.nih.gov/pubmed/27994643 http://dx.doi.org/10.3332/ecancer.2016.687 |
Ejemplares similares
-
A Novel Care Model for Neonatal Intestinal Failure Patients Is Associated With Cost Savings and Improved Outcomes
por: Johnson, Erin, et al.
Publicado: (2019) -
Breast Cancer: Impact of New Treatments?
por: Storme, Guy A.
Publicado: (2023) -
Specificity of HTLV screening tests and its impact on health care program costs: The perspective of antenatal screening in Brazil
por: Rosadas, Carolina, et al.
Publicado: (2021) -
Augmented renal clearance in critically ill COVID-19 patients: Forewarned is forearmed
por: Dhaese, Sofie, et al.
Publicado: (2021) -
The cost of cancer treatment in Portugal
por: Lopes, José Machado, et al.
Publicado: (2017)